With the Solar Eclipse, Millions Understand That Science is Not Fake News

At 10:21 a.m. Los Angeles time on Monday, August 21st, the moon covered 62% of the sun. In Oregon and across the US, there were 2.3 minutes of total darkness. Scientists had been informing everyone about this upcoming event for many years, and it occurred exactly on schedule: a natural event.

Positive Butterfly News, Immune Tweaking with CRISPR, and Looking to the Future in China

As I reported in a previous blog, not only does the herbicide Roundup cause lymphomas and myeloma, its widespread use on GMO (genetically modified organism) crops has decimated milkweed, an herbaceous perennial and the essential food for monarch butterflies. Since 1990, about 970 million monarchs have vanished.

Gene Editing, Regulating DNA Sequencing Tests, and How Your Body Gets Its Energy

Scientific breakthroughs in the news this week promise many practical implications for myeloma patients.

Saturated fat reconsidered, traces of herbicide in ice cream, and a curcumin success story

News about food is often a mix of conflicting advice and dubious claims. Three thought-provoking articles published this week caught my eye and offer plenty of food for thought.

A busy news week focuses on drug access and costs

Patent extensions upheld and revealed

On Monday, July 17th, a US appeals court ruled that a patent on Takeda Pharmaceutical’s drug Velcade® (bortezomib) was extended to 2022. Generic drug companies had sued to invalidate Takeda’s patents but failed. This means that there will be no generic competition before the 2022 date. This is obviously very good news for Takeda and eliminates hopes that cheaper generics would be available much sooner. Paradoxically, this will also benefit Amgen’s Kyprolis® (carfilzomib), the other major proteasome inhibitor, which would have faced much stiffer competition from a much lower priced generic.